ID   CAPS1_RAT               Reviewed;        1289 AA.
AC   Q62717;
DT   10-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JAN-2024, entry version 152.
DE   RecName: Full=Calcium-dependent secretion activator 1;
DE   AltName: Full=Calcium-dependent activator protein for secretion 1;
DE            Short=CAPS-1;
DE            Short=rCAPS;
GN   Name=Cadps; Synonyms=Caps, Caps1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 103-109; 560-595; 810-821
RP   AND 1155-1183, CALCIUM-BINDING, AND TISSUE SPECIFICITY.
RX   PubMed=9289490; DOI=10.1074/jbc.272.32.19637;
RA   Ann K., Kowalchyk J.A., Loyet K.M., Martin T.F.J.;
RT   "Novel Ca2+-binding protein (CAPS) related to UNC-31 required for Ca2+-
RT   activated exocytosis.";
RL   J. Biol. Chem. 272:19637-19640(1997).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=1516133; DOI=10.1016/0092-8674(92)90310-9;
RA   Walent J.H., Porter B.W., Martin T.F.J.;
RT   "A novel 145 kd brain cytosolic protein reconstitutes Ca(2+)-regulated
RT   secretion in permeable neuroendocrine cells.";
RL   Cell 70:765-775(1992).
RN   [3]
RP   FUNCTION.
RX   PubMed=9162085; DOI=10.1074/jbc.272.22.14447;
RA   Martin T.F.J., Kowalchyk J.A.;
RT   "Docked secretory vesicles undergo Ca2+-activated exocytosis in a cell-free
RT   system.";
RL   J. Biol. Chem. 272:14447-14453(1997).
RN   [4]
RP   PHOSPHOINOSIDE-BINDING.
RX   PubMed=9525942; DOI=10.1074/jbc.273.14.8337;
RA   Loyet K.M., Kowalchyk J.A., Chaudhary A., Chen J., Prestwich G.D.,
RA   Martin T.F.J.;
RT   "Specific binding of phosphatidylinositol 4,5-bisphosphate to calcium-
RT   dependent activator protein for secretion (CAPS), a potential
RT   phosphoinositide effector protein for regulated exocytosis.";
RL   J. Biol. Chem. 273:8337-8343(1998).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9697858; DOI=10.1016/s0896-6273(00)80521-8;
RA   Berwin B., Floor E., Martin T.F.J.;
RT   "CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-
RT   core vesicle exocytosis.";
RL   Neuron 21:137-145(1998).
RN   [6]
RP   FUNCTION.
RX   PubMed=9697859; DOI=10.1016/s0896-6273(00)80522-x;
RA   Tandon A., Bannykh S., Kowalchyk J.A., Banerjee A., Martin T.F.J.,
RA   Balch W.E.;
RT   "Differential regulation of exocytosis by calcium and CAPS in semi-intact
RT   synaptosomes.";
RL   Neuron 21:147-154(1998).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10792045; DOI=10.1073/pnas.090359097;
RA   Rupnik M., Kreft M., Sikdar S.K., Grilc S., Romih R., Zupancic G.,
RA   Martin T.F.J., Zorec R.;
RT   "Rapid regulated dense-core vesicle exocytosis requires the CAPS protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5627-5632(2000).
RN   [8]
RP   SUBCELLULAR LOCATION, DOMAIN, PHOSPHOINOSIDE-BINDING, AND MUTAGENESIS OF
RP   LYS-531; 537-TRP--ARG-540; 558-ARG--LYS-561 AND LYS-561.
RX   PubMed=11927595; DOI=10.1074/jbc.m201614200;
RA   Grishanin R.N., Klenchin V.A., Loyet K.M., Kowalchyk J.A., Ann K.,
RA   Martin T.F.J.;
RT   "Membrane association domains in Ca2+-dependent activator protein for
RT   secretion mediate plasma membrane and dense-core vesicle binding required
RT   for Ca2+-dependent exocytosis.";
RL   J. Biol. Chem. 277:22025-22034(2002).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=14530279; DOI=10.1074/jbc.m304727200;
RA   Speidel D., Varoqueaux F., Enk C., Nojiri M., Grishanin R.N.,
RA   Martin T.F.J., Hofmann K., Brose N., Reim K.;
RT   "A family of Ca2+-dependent activator proteins for secretion: comparative
RT   analysis of structure, expression, localization, and function.";
RL   J. Biol. Chem. 278:52802-52809(2003).
RN   [10]
RP   FUNCTION, AND MUTAGENESIS OF GLY-476.
RX   PubMed=15312653; DOI=10.1016/j.neuron.2004.07.028;
RA   Grishanin R.N., Kowalchyk J.A., Klenchin V.A., Ann K., Earles C.A.,
RA   Chapman E.R., Gerona R.R.L., Martin T.F.J.;
RT   "CAPS acts at a prefusion step in dense-core vesicle exocytosis as a PIP2
RT   binding protein.";
RL   Neuron 43:551-562(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89; SER-96 AND SER-259, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Calcium-binding protein involved in exocytosis of vesicles
CC       filled with neurotransmitters and neuropeptides. Probably acts upstream
CC       of fusion in the biogenesis or maintenance of mature secretory
CC       vesicles. Regulates catecholamine loading of DCVs. May specifically
CC       mediate the Ca(2+)-dependent exocytosis of large dense-core vesicles
CC       (DCVs) and other dense-core vesicles by acting as a PtdIns(4,5)P2-
CC       binding protein that acts at prefusion step following ATP-dependent
CC       priming and participates in DCVs-membrane fusion. However, it may also
CC       participate in small clear synaptic vesicles (SVs) exocytosis and it is
CC       unclear whether its function is related to Ca(2+) triggering.
CC       {ECO:0000269|PubMed:10792045, ECO:0000269|PubMed:1516133,
CC       ECO:0000269|PubMed:15312653, ECO:0000269|PubMed:9162085,
CC       ECO:0000269|PubMed:9697858, ECO:0000269|PubMed:9697859}.
CC   -!- SUBUNIT: Interacts with the dopamine receptor DRD2 (By similarity).
CC       Interacts with RASL10B (By similarity). Homodimer. {ECO:0000250,
CC       ECO:0000269|PubMed:1516133}.
CC   -!- INTERACTION:
CC       Q62717; P32851: Stx1a; NbExp=3; IntAct=EBI-15804323, EBI-539720;
CC   -!- SUBCELLULAR LOCATION: Synapse {ECO:0000269|PubMed:10792045,
CC       ECO:0000269|PubMed:11927595, ECO:0000269|PubMed:14530279,
CC       ECO:0000269|PubMed:1516133, ECO:0000269|PubMed:9697858}. Cytoplasmic
CC       vesicle, secretory vesicle, neuronal dense core vesicle membrane
CC       {ECO:0000269|PubMed:10792045, ECO:0000269|PubMed:11927595,
CC       ECO:0000269|PubMed:9697858}; Peripheral membrane protein {ECO:0000305}.
CC       Note=Membrane-associated to vesicles. Strongly enriched in synaptic
CC       fractions. Preferentially binds to dense core vesicles but not to
CC       synaptic vesicles. Binds phosphoinosides, with a strong selectivity for
CC       PtdIns(4,5)P2 over PtdIns(3,4,5)P3. Probably localizes to different
CC       vesicles compared to CADPS2. {ECO:0000269|PubMed:10792045,
CC       ECO:0000269|PubMed:11927595, ECO:0000269|PubMed:14530279,
CC       ECO:0000269|PubMed:1516133, ECO:0000269|PubMed:9697858}.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in neural and endocrine
CC       secretory tissues. Expressed in brain, pancreas, hypothalamus,
CC       pituitary and adrenal but not in heart, placenta, lung, liver, skeletal
CC       muscle or kidney. In brain, it is absent from the cell body layers of
CC       the hippocampus and dentate gyrus but abundant in the synaptic
CC       neuropil, except for the stratum lucidum and stratum lacunosum
CC       moleculare where it is not detected. In the cerebellum, it is mainly
CC       detected in the glomeruli of the granule cell layer where it
CC       colocalized with synaptophysin. In the olfactory bulb, it is detected
CC       mainly in the glomeruli. In the adult adrenal gland, where it is
CC       restricted to the medulla (at protein level).
CC       {ECO:0000269|PubMed:14530279, ECO:0000269|PubMed:9289490,
CC       ECO:0000269|PubMed:9697858}.
CC   -!- DOMAIN: The PH domain is essential for regulated exocytosis and binds
CC       phospholipids and plasma membrane. It however does not mediate binding
CC       to DCVs. {ECO:0000269|PubMed:11927595}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U16802; AAB88635.1; -; mRNA.
DR   PIR; I84505; I84505.
DR   RefSeq; NP_037351.1; NM_013219.1.
DR   PDB; 6A68; X-ray; 2.90 A; A=859-1036.
DR   PDB; 7VS3; X-ray; 2.60 A; A=391-634.
DR   PDBsum; 6A68; -.
DR   PDBsum; 7VS3; -.
DR   AlphaFoldDB; Q62717; -.
DR   SMR; Q62717; -.
DR   BioGRID; 247806; 5.
DR   DIP; DIP-58640N; -.
DR   IntAct; Q62717; 3.
DR   MINT; Q62717; -.
DR   STRING; 10116.ENSRNOP00000012153; -.
DR   GlyGen; Q62717; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q62717; -.
DR   PhosphoSitePlus; Q62717; -.
DR   jPOST; Q62717; -.
DR   PaxDb; 10116-ENSRNOP00000012153; -.
DR   GeneID; 26989; -.
DR   KEGG; rno:26989; -.
DR   AGR; RGD:708573; -.
DR   CTD; 8618; -.
DR   RGD; 708573; Cadps.
DR   eggNOG; KOG3543; Eukaryota.
DR   InParanoid; Q62717; -.
DR   OrthoDB; 5399598at2759; -.
DR   PRO; PR:Q62717; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0031045; C:dense core granule; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0098674; C:extrinsic component of neuronal dense core vesicle membrane; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:WormBase.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0050432; P:catecholamine secretion; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0006887; P:exocytosis; IBA:GO_Central.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IMP:RGD.
DR   GO; GO:0045921; P:positive regulation of exocytosis; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0099525; P:presynaptic dense core vesicle exocytosis; ISO:RGD.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0045055; P:regulated exocytosis; TAS:RGD.
DR   GO; GO:0016082; P:synaptic vesicle priming; ISO:RGD.
DR   GO; GO:0016050; P:vesicle organization; ISO:RGD.
DR   CDD; cd01234; PH_CADPS; 1.
DR   Gene3D; 1.10.357.50; -; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR033227; CAPS.
DR   InterPro; IPR010439; MUN_dom.
DR   InterPro; IPR014770; Munc13_1.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   PANTHER; PTHR12166; CALCIUM-DEPENDENT SECRETION ACTIVATOR; 1.
DR   PANTHER; PTHR12166:SF6; CALCIUM-DEPENDENT SECRETION ACTIVATOR 1; 1.
DR   Pfam; PF06292; MUN; 1.
DR   Pfam; PF00169; PH; 1.
DR   SMART; SM01145; DUF1041; 1.
DR   SMART; SM00233; PH; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS51258; MHD1; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cytoplasmic vesicle; Direct protein sequencing;
KW   Exocytosis; Lipid-binding; Membrane; Metal-binding; Phosphoprotein;
KW   Protein transport; Reference proteome; Synapse; Transport.
FT   CHAIN           1..1289
FT                   /note="Calcium-dependent secretion activator 1"
FT                   /id="PRO_0000053866"
FT   DOMAIN          378..493
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          519..622
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          916..1047
FT                   /note="MHD1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00587"
FT   REGION          1..107
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          788..1065
FT                   /note="Interaction with DRD2"
FT                   /evidence="ECO:0000250"
FT   REGION          1113..1289
FT                   /note="Mediates targeting and association with DCVs"
FT   REGION          1264..1289
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..17
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        31..45
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TJ1"
FT   MOD_RES         89
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         96
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         476
FT                   /note="G->E: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:15312653"
FT   MUTAGEN         531
FT                   /note="K->E: No effect."
FT                   /evidence="ECO:0000269|PubMed:11927595"
FT   MUTAGEN         537..540
FT                   /note="WKKR->SQKE: Affects PtdIns(4,5)P2-binding, plasma
FT                   membrane-association but not binding to DCVs."
FT                   /evidence="ECO:0000269|PubMed:11927595"
FT   MUTAGEN         558..561
FT                   /note="REKK->DEEE: Affects PtdIns(4,5)P2-binding, plasma
FT                   membrane-association but not binding to DCVs."
FT                   /evidence="ECO:0000269|PubMed:11927595"
FT   MUTAGEN         561
FT                   /note="K->E: Affects PtdIns(4,5)P2-binding, plasma
FT                   membrane-association but not binding to DCVs."
FT                   /evidence="ECO:0000269|PubMed:11927595"
FT   STRAND          396..406
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          416..423
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          428..430
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          440..450
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          456..463
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          472..480
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          491..494
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          499..502
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          507..514
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          520..534
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          538..546
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          548..550
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          552..557
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          565..569
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          574..577
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          588..595
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   STRAND          598..606
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   HELIX           607..621
FT                   /evidence="ECO:0007829|PDB:7VS3"
FT   HELIX           869..921
FT                   /evidence="ECO:0007829|PDB:6A68"
FT   HELIX           933..944
FT                   /evidence="ECO:0007829|PDB:6A68"
FT   TURN            947..951
FT                   /evidence="ECO:0007829|PDB:6A68"
FT   HELIX           953..981
FT                   /evidence="ECO:0007829|PDB:6A68"
FT   HELIX           982..984
FT                   /evidence="ECO:0007829|PDB:6A68"
FT   HELIX           1001..1015
FT                   /evidence="ECO:0007829|PDB:6A68"
SQ   SEQUENCE   1289 AA;  146266 MW;  2ADAEA35FB20BCDD CRC64;
     MLDPSSSEEE SDEILEEESG KEVLGSAASG ARLSPSRTNE GSAGSAGMGG SGAGAGVGAG
     GGGGSGASSG GGAGGLQPSS RAGGGRPSSP SPSVVSEKEK EELERLQKEE EERKKRLQLY
     VFVMRCIAYP FNAKQPTDMA RRPRKISKQQ LQTVKDRFQA FLNGETQIVA DEAFMNAVQS
     YYEVFLKSDR VARMVQSGGC SANDSREVFK KHIEKRVRSL PEIDGLSKET VLSSWMAKFD
     AIYRGEEDPR KQQARMTASA ASELILSKEQ LYEMFQNILG IKKFEHQLLY NACQLDNPDE
     QAAQIRRELD GRLQMADQIA RERKFPKFVS KEMENMYIEE LKSSVNLLMA NLESMPVSKG
     GEFKLQKLKR SHNASIIDMG EESENQLSKS DVLLSFSLEV VIMEVQGLKS LAPNRIVYCT
     MEVEGGEKLQ TDQAEASKPT WGTQGDFSTT HALPAVKVKL FTESTGVLAL EDKELGRVIL
     HPTPNSPKQS EWHKMTVSKN CPDQDLKIKL AVRMDKPQNM KHSGYLWTIG KNVWKRWKKR
     FFVLVQVSQY TFAMCSYREK KAEPQELLQL DGYTVDYTDP QPGLEGGRAF FNAVKEGDTV
     IFASDDEQDR ILWVQAMYRA TGQSHKPVPP TQVQKLKPRA ETCLSMDAPI SQFYADRAQK
     HGMDEFISSN PCNFDHASLF EMVQRLTLDH RLNDSYSCLG WFSPGQVFVL DEYCARNGVR
     GCHRHLCYLR DLLERAENGA MIDPTLLHYS FAFCASHVHG NRPDGIGTVT VEEKERFEEI
     KERLRVLLEN QITHFRYCFP FGRPEGALKA TLSLLERVLM KDIVTPVPQE EVKTVIRKCL
     EQAALVNYSR LSEYAKIEEN VGRLITPAKK LEDTIRLAEL VIEVLQQNEE HHAEAFAWWS
     DLMVEHAETF LSLFAVDMDA ALEVQPPDTW DSFPLFQLLN DFLRTDYNLC NGKFHKHLQD
     LFAPLVVRYV DLMESSIAQS IHRGFERESW EPVNNGSGTS EDLFWKLDAL QTFIRDLHWP
     EEEFGKHLEQ RLKLMASDMI ESCVKRTRIA FEVKLQKTSR STDFRVPQSI CTMFNVMVDA
     KAQSTKLCSM EMGQEHQYHS KIDELIEETV KEMITLLVAK FVTILEGVLA KLSRYDEGTL
     FSSFLSFTVK AASKYVDVPK PGMDVADAYV TFVRHSQDVL RDKVNEEMYI ERLFDQWYNS
     SMNVICTWLT DRMDLQLHIY QLKTLIRMVK KTYRDFRLQG VLDSTLNSKT YETIRNRLTV
     EERTASVSEG GGLQGISMKD SDEEDEEDD
//
